Evidence map›Paper›PMID 32764489›Full record

ArticleCancers2020

Therapeutic Zfra4-10 or WWOX7-21 Peptide Induces Complex Formation of WWOX with Selective Protein Targets in Organs that Leads to Cancer Suppression and Spleen Cytotoxic Memory Z Cell Activation In Vivo.

Wan-Pei Su, Wan-Jen Wang, Jean-Yun Chang, Pei-Chuan Ho, Tsung-Yun Liu, Kuang-Yu Wen, Hsiang-Ling Kuo, Yu-Jie Chen, Shenq-Shyang Huang, Dudekula Subhan and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Hyaluronan: An Architect and Integrator for Cancer and Neural Diseases.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Zfra Inhibits the TRAPPC6AΔ-Initiated Pathway of Neurodegeneration.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Wan-Pei SuLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Wan-Jen WangLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Jean-Yun ChangLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Pei-Chuan HoLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Tsung-Yun LiuLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Kuang-Yu WenLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Hsiang-Ling KuoLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Yu-Jie ChenLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Shenq-Shyang HuangLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Dudekula SubhanLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Yu-An ChenLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Chen-Yu LuLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Chia-Yun WuLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Sing-Ru LinLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Ming-Hui LeeLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.
Ming-Fu ChiangDepartment of Neurosurgery, Mackay Memorial Hospital, Taipei 10449, Taiwan.
Chun-I SzeDepartment of Cell Biology and Anatomy, National Cheng Kung University, Tainan 70101, Taiwan.ORCID 0000-0002-1316-1650
Nan-Shan ChangLaboratory of Molecular Immunology, Institute of Molecular Medicine, National Cheng Kung University, College of Medicine, Tainan 70101 Taiwan.ORCID 0000-0002-6889-8756
National Cheng Kung University · TWChina Medical University · TWMackay Memorial Hospital · TW

Funding

Ministry of Science and Technology, Taiwan 105-2320-B-006-036Ministry of Science and Technology, Taiwan 105-2320-B-006-046Ministry of Science and Technology, Taiwan 106-2320-B-006-017Ministry of Science and Technology, Taiwan 106-2320-B-006-061Ministry of Science and Technology, Taiwan 107-2320-B-006-005Ministry of Science and Technology, Taiwan 107-2320-B-006-058-MY3National Health Research Institutes NHRI-EX107-10734NI
6 · The paper itself

Abstract

Synthetic Zfra4-10 and WWOX7-21 peptides strongly suppress cancer growth in vivo. Hypothetically, Zfra4-10 binds to the membrane Hyal-2 of spleen Z cells and activates the Hyal-2/WWOX/SMAD4 signaling for cytotoxic Z cell activation to kill cancer cells. Stimulation of membrane WWOX in the signaling complex by a WWOX epitope peptide, WWOX7-21, is likely to activate the signaling. Here, mice receiving Zfra4-10 or WWOX7-21 peptide alone exhibited an increased binding of endogenous tumor suppressor WWOX with ERK, C1qBP, NF-κB, Iba1, p21, CD133, JNK1, COX2, Oct4, and GFAP in the spleen, brain, and/or lung which led to cancer suppression. However, when in combination, Zfra4-10 and WWOX7-21 reduced the binding of WWOX with target proteins and allowed tumor growth in vivo. In addition to Zfra4-10 and WWOX7-21 peptides, stimulating the membrane Hyal-2/WWOX complex with Hyal-2 antibody and sonicated hyaluronan (HAson) induced Z cell activation for killing cancer cells in vivo and in vitro. Mechanistically, Zfra4-10 binds to membrane Hyal-2, induces dephosphorylation of WWOX at pY33 and pY61, and drives Z cell activation for the anticancer response. Thus, Zfra4-10 and WWOX7-21 peptides, HAson, and the Hyal-2 antibody are of therapeutic potential for cancer suppression.

Indexed as

Hyal-2Hyal-2+ CD3- CD19- lymphocyteHyaluronanphosphorylationWWOXZfraZ lymphocyte

Identifiers

PMID32764489
PMCPMC7464583
OpenAlexW3046958605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.